Evidence map›Paper›PMID 42522895›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026

Obesity Disrupts CtBP2-Mediated Maintenance of Transcriptional Equilibrium in Hypothalamic Feeding Circuitry.

Wanpei Chen, Kenta Kainoh, Kenji Saito, Takaaki Matsuda, Daichi Yamazaki, Yuto Kobari, Ayumi Nakata, Nao Aono-Soma, Takafumi Miyamoto, Yuki Murayama and 6 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Wanpei ChenDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Kenta KainohDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Kenji SaitoDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Takaaki MatsudaDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Daichi YamazakiDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Yuto KobariDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Ayumi NakataDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Nao Aono-SomaDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Takafumi MiyamotoDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Yuki MurayamaDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Yoko SuganoDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Yoshinori OsakiDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Hitoshi IwasakiDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Takashi MatsuzakaDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Hitoshi ShimanoDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Motohiro SekiyaDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.ORCID https://orcid.org/0000-0002-5170-9699

Funding

Astellas|Astellas Foundation for Research on Metabolic Disorders (AFRMD)Japan Agency for Medical Research and Development (AMED) JP18gm5910007Japan Agency for Medical Research and Development (AMED) JP22ek0210175Japan Agency for Medical Research and Development (AMED) JP256f0137008Japan Agency for Medical Research and Development (AMED) JP25gm6710004Japan Diabetes FoundationManpei Suzuki Diabetes FoundationMEXT | Japan Society for the Promotion of Science (JSPS) 23K18270MEXT | Japan Society for the Promotion of Science (JSPS) 26K02846Ono Medical Research FoundationSuzuken Memorial Foundation (SMF)Takeda Science Foundation (TSF)
6 · The paper itself

Abstract

Feeding behavior, which is crucial for all mammals, is regulated by a delicate equilibrium between the orexigenic and anorexigenic activities of hypothalamic neurons. This exquisite control of the neuropeptides that govern the feeding behavior could be a focal point in the pathogenesis of obesity. We reported that inactivation of C-terminal binding protein 2 (CtBP2), a transcriptional corepressor with metabolite-sensing capabilities, contributes to the pathogenesis of obesity in liver tissues and pancreatic β-cells. Here, we describe a transcriptional system regulated by CtBP2 in the hypothalamus. Our global mapping of CtBP2 binding sites using ChIP-seq combined with functional analyses revealed that CtBP2 functions as a corepressor for orexigenic neuropeptide promoters. In response to the metabolic abnormalities associated with obesity, CtBP2 undergoes allosteric inactivation and dissociates from these promoters, thereby resulting in the derepression of orexigenic neuropeptide expression. Consistently, the loss of CtBP2 in hypothalamic neurons in mice increases the expression of orexigenic neuropeptides, thus leading to increased feeding behavior. These findings highlight how obesity disrupts homeostatic mechanisms that normally maintain body weight within a healthy range.

Indexed as

Alcohol OxidoreductasesFeeding BehaviorHypothalamusNerve Tissue ProteinsObesityTranscription, GeneticAnimalsCo-Repressor ProteinsGene Expression RegulationMaleMiceMice, Inbred C57BLNeuronsNeuropeptidesPromoter Regions, GeneticAlcohol OxidoreductasesCo-Repressor ProteinsCtbp2 protein, mouseNerve Tissue ProteinsNeuropeptidesAgRPCtBP2hypothalamusmetabolite sensorNPYobesity

Identifiers

PMID42522895
PMCPMC13417749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.